adenosine monophosphate has been researched along with Anxiety in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Agostini, C; Bernardo, P; Caniato, F; Cappelli, F; Di Filippo, C; Di Mario, C; Mattesini, A; Meucci, F; Sori, A; Stolcova, M | 1 |
| Baldissarelli, LA; Bogo, MR; Bonan, CD; Capiotti, KM; Ghisleni, G | 1 |
| Collins, P; Gershon, S; Sakalis, G; Sathananthan, G | 1 |
1 trial(s) available for adenosine monophosphate and Anxiety
| Article | Year |
|---|---|
SQ 65,396: a non-sedative anxiolytic?
Topics: Adenosine Monophosphate; Adult; Anxiety; Butylamines; Clinical Trials as Topic; Humans; Middle Aged; Phosphodiesterase Inhibitors; Placebos; Psychiatric Status Rating Scales; Pyrazoles; Pyridines; Tranquilizing Agents | 1974 |
2 other study(ies) available for adenosine monophosphate and Anxiety
| Article | Year |
|---|---|
Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.
Topics: Adenosine Monophosphate; Aged; Anxiety; Chest Pain; Coronary Angiography; Coronary Occlusion; Drug Substitution; Drug-Eluting Stents; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Electrocardiography; Humans; Inferior Wall Myocardial Infarction; Male; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome; Withholding Treatment | 2021 |
Arsenic alters behavioral parameters and brain ectonucleotidases activities in zebrafish (Danio rerio).
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Anxiety; Arsenates; Behavior, Animal; Brain; Female; Hydrolysis; Locomotion; Male; Nucleoside-Triphosphatase; Toxicity Tests; Water Pollutants, Chemical; Zebrafish | 2012 |